• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   1990-1999  
Title Created Date
Growth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs 25 May 2013
Prolactin receptor gene expression in lymphoid cells 12 May 2013
Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis 10 May 2013
Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial 09 May 2013
Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography 09 May 2013
In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue 01 May 2013
In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas 01 May 2013
Antiproliferative effect of carotenoids on human colon cancer cells without conversion to retinoic acid 22 April 2013
111In-octreotide scintigraphy in oncology 14 April 2013
Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation 13 February 2013
Display # 

Page 59 of 60

  • Start
  • Prev
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • Next
  • End

Search

Follow us...

Latest

  • Beneficial properties of melatonin in an experimental model of pancreatic cancer
  • Combinatory Effects of Indoximod and Melatonin Alleviate Myeloid Derived Suppressor Cells Driven Triple Negative Breast Cancer Progression and Metastasis
  • Antitumour activity of melatonin in a mouse model of human prostate cancer: relationship with hypoxia signalling
  • Vitamin D decreases tumor cell growth and invasiveness in primary malignant bone tumors in vitro
  • Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial
  • Synergistic In Vitro Effects of Minor Phytocannabinoids and Melatonin Combinations Against Human Glioblastoma Cells
  • Melatonin as a Promising Agent to Treat Ovarian Cancer: Molecular Mechanisms
  • Pharmacologic targeting of the dopamine D2 receptor impacts the efficacy of immune checkpoint blockade in melanoma
  • Dose-Dependency of Antitumor Effects of the Pineal Hormone Melatonin in Untreatable Metastatic Solid Tumor Patients
  • Impaired redox adaptation through SLC38A5-dependent glutamine metabolism contributes to melatonin-mediated anoikis sensitivity and metastasis suppression in bone cancer
  • Does the use of melatonin overcome drug resistance in cancer chemotherapy?
  • Adjuvant chemotherapy with melatonin for targeting human cancers: A review
  • A Preliminary Phase-2 Study with very High-Dose of Melatonin (1000 mg/day) in Untreatable Advanced Cancer Patients Already Progression on Previous Palliative Therapy with High-Dose Melatonin
  • Melatonin and Vitamins: A Promising Combination to Augment Conventional Anticancer Therapies
  • Neuroimmune treatment of advanced solid tumors: 3-year survival after angiotensin 1-7, pineal indoles, and cannabinoids
  • Melatonin as an Adjuvant to Antiangiogenic Cancer Treatments
  • Melatonin: A Powerful Integrative Adjunctive Agent for Oncology
  • Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Somatostatin in oncology, the overlooked evidences
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • How effective is chemo therapy?
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer